Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
Search
Close this search box.
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
Menu
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Translational epigenomics: dissecting cell type-specific function of neuropsychiatric risk genes in vivo

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective Our objective is to enable scalable genetic screening to study how different cell types and epigenetic networks are impacted by risk genes implicated in human psychiatric disorders. Impact…

Continue ReadingTranslational epigenomics: dissecting cell type-specific function of neuropsychiatric risk genes in vivo

Role of ataxin-3 polyadenylation site selection in ALS neuron toxicity and disease pathogenesis

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective Here we will study the role of ataxin-3 alternative polyadenylation in the pathogenesis of ALS, and test if ASOs can reduce distal polyadenylation of ataxin-3 to rescue ALS…

Continue ReadingRole of ataxin-3 polyadenylation site selection in ALS neuron toxicity and disease pathogenesis

B cell receptor-mediated lentiviral expression of anti-HIV antibody

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective With a single administration to an individual, lentiviral vectors that selectively transduce B cells in vivo and express highly potent anti-HIV-1 proteins to suppress HIV-1 replication throughout life…

Continue ReadingB cell receptor-mediated lentiviral expression of anti-HIV antibody

Developing a universal CRISPR gene therapy approach to treat C9orf72 ALS

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective Development of a CRISPR genome editing therapy for ALS caused by C9orf72 and the delivery vehicle required to bring this novel therapy to patients. Impact A cure for…

Continue ReadingDeveloping a universal CRISPR gene therapy approach to treat C9orf72 ALS

Modulating cardiac myosin heavy chain isoform expression for treating cardiomyopathies

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective To discover CRISPR-based genetic strategies that will directly and therapeutically modify cardiac myosin heavy chain isoform expression to treat HF and cardiomyopathies. Impact Heart Failure and Cardiomyopathies Major…

Continue ReadingModulating cardiac myosin heavy chain isoform expression for treating cardiomyopathies

Development of a VAV2 antisense oligonucleotide (ASO) treatment for ALS

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective Patient specific stem cells (iPSCs) to model ALS and identify a broadly acting therapeutic intervention Impact Heterogenous patient population, dire need for broadly acting therapeutic interventions Major Proposed…

Continue ReadingDevelopment of a VAV2 antisense oligonucleotide (ASO) treatment for ALS

Treatment of Myasthenic Syndrome due to Choline Acetyltransferase Deficiency Using AAV9-mediated Gene Therapy

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective Use of a viral vector to transport a normal gene to children with severe motor and respiratory disabilities caused by an inborn defect of the choline acetyltransferase (ChAT)…

Continue ReadingTreatment of Myasthenic Syndrome due to Choline Acetyltransferase Deficiency Using AAV9-mediated Gene Therapy

C9orf72 repeat expansion-tuned allelic suppression by CRISPRi as an ALS therapy

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective We aim to discover an adeno-associated viral (AAV) CRISPRi gene therapy for amyotrophic lateral sclerosis (ALS) patients with hexanucleotide repeat expansions in the C9orf72 gene. Impact This therapy…

Continue ReadingC9orf72 repeat expansion-tuned allelic suppression by CRISPRi as an ALS therapy

Development of an Optogenetic Vision Restoration Gene Therapy Using an Engineered Form of Melanopsin

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective The objective of this research proposal is to develop a lead AAV candidate for an optogenetic vision restoration therapy for patients suffering from blindness due to loss of…

Continue ReadingDevelopment of an Optogenetic Vision Restoration Gene Therapy Using an Engineered Form of Melanopsin

RNA-based therapeutics to augment regulatory T cells: a novel approach to treat myocarditis

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective Use human cell therapy insights, specifically CDC-secreted EV analysis, to develop a noncoding RNA chemical entity for myocarditis treatment. Impact Key knowledge gap is how to recruit adaptive…

Continue ReadingRNA-based therapeutics to augment regulatory T cells: a novel approach to treat myocarditis
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us